|
This report is being submitted as part of remediation activities associated with capa 643143, addressing mdr reporting guidance from the fda¿s 1995 preamble, which ensures complaints related to corrections and recalls previously reported to the fda under 21 cfr 806 are now reported as mdrs; this is not a new malfunction/event.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Medtronic received information that during the implant of this transcatheter bioprosthetic valve, the delivery catheter system (dcs) capsule was intentionally over-driven in order to navigate the unfavorable angle of the patient anatomy.The dcs was hugging the lesser curve and did not line up correctly with the annular plane.After three recaptures and after the dcs had been over-driven twice, the actuator handle separated during attempted deployment.The valve was recaptured and the system was removed.A new dcs was used for successful implant.There was not a loose tab present in the packaging and both knobs were intact.It was noted that the loader was experienced.No additional damage was noted on the deployment knob.No adverse patient effects were reported.
|